Pharmacogenetic of Doxorubicin in HCC.

Clinical trial NCT06313047 · COMPLETED

Trial details

NCT number: NCT06313047
Sponsor: Rehab Werida
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatocellular Carcinoma

Start date: 2021-01-01
Primary completion: 2023-12-15
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.